Rekombinanter MTAP Antikörper (AA 97-196)
Kurzübersicht für Rekombinanter MTAP Antikörper (AA 97-196) (ABIN7877261)
Target
Alle MTAP Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 97-196
-
Verwendungszweck
- Recombinant MTAP Antibody / S-methyl-5'-thioadenosine phosphorylase (azide and preservative free)
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A recombinant human partial protein (amino acids 97-196) was used as the immunogen for this MTAP antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant MTAP antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the recombinant MTAP antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- MTAP (Methylthioadenosine phosphorylase (MTAP))
-
Andere Bezeichnung
- MTAP
-
Hintergrund
- Recognizes a protein of 31 kDa, which is identified as MTAP (5'-deoxy-5'-methylthioadenosine phosphorylase). It catalyzes the reversible phosphorolysis of methylthioadenosine, which is important in polyamine metabolism and for the salvage of adenine and methionine. The gene encoding MTAP is linked to the tumor suppressor gene, p16INK4A. Deficient levels of MTAP can occur in cancers primarily through co-deletion of the MTAP gene and the p16INK4A gene. Cells expressing MTAP and possessing adenine salvage pathway activity may be less susceptible to malignancy due to growth-inhibitory actions of agents (e.g. antifolates), whose mechanism of action, in part, involves this de novo purine pathway.
-
UniProt
- Q13126
-
Pathways
- Ribonucleoside Biosynthetic Process, Methionine Biosynthetic Process
Target
-